About Sparta Biomedical
Sparta Biomedical is a Healthcare company based in United States founded in 2017 by Dimitrios Angelis. Synthetic cartilage platforms are developed for orthopedic surgeons. Sparta Biomedical has raised $5 million across 2 funding rounds from investors including Duke University and Nanosha. Sparta Biomedical offers products and services including Galene Platform and Ormi™ Implant. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is Sparta Biomedical Inc. Its competitors include Moximed, Allay Therapeutics and Optimotion Implants; 3 of its 3 listed competitors have raised funding.
Company details
Sparta Biomedical was founded in 2017 and is based in Research Triangle Park, United States. Advancements in biomedical engineering are focused on by the company, particularly through the creation of a synthetic cartilage platform. This platform is designed to assist orthopedic surgeons in restoring patient movement. Operations center on research and development within the orthopedics sector, with services aimed at improving surgical outcomes.
- Headquarters Research Triangle Park, United States
- Founders Dimitrios Angelis
- SectorsHealthcare
- Email••••••••
- Website spartabiomedical.com
- Social LinkedIn Facebook Instagram
- Legal Name Sparta Biomedical Inc
- Total Equity Funding$5M (USD)
in 2 rounds
- InvestorsDuke University
& 1 more
Products & Services of Sparta Biomedical
Sparta Biomedical offers a comprehensive portfolio of products and services, including Galene Platform and Ormi™ Implant.
Chemically engineered cartilage for treating osteoarthritis in joints
Implant for partial knee cartilage restoration and mobility improvement
Funding Insights of Sparta Biomedical
Sparta Biomedical has successfully raised a total of $5M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5M
- Total Rounds 2
- First Round $5M
(Dec 2021)
- Investors Count 2
All 2 funding rounds of Sparta Biomedical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | Debt – Convertible | – | – | – | |
| Dec 2021 | $5M | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Sparta Biomedical
Sparta Biomedical has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Duke University and Nanosha.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| nanoshallc.tcc.mode | ||||
Multiple courses and degrees across diversified streams are offered. | 1838 | duke.edu | United States |
Investor details for Sparta Biomedical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sparta Biomedical
1 people are tracked at Sparta Biomedical (1 in leadership).
| Name | Role | Group |
|---|---|---|
Dimitrios Angelis | Co-Founder | Leadership |
Complete people profiles for Sparta Biomedical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sparta Biomedical
3 dated milestones of Sparta Biomedical across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Sparta Biomedical is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Debt – Convertible,.
Competitors of Sparta Biomedical
Sparta Biomedical has 3 listed competitors in our database, 3 of them funded. They include Moximed, Allay Therapeutics and Optimotion Implants.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| moximed.com | 2006 | Hayward, United States | $262.34M | 15 | A knee implant for pre-arthroplasty osteoarthritis patients is developed. | |
| allaytx.com | 2017 | Menlo Park, United States | $146.89M | Post-surgical pain drugs are developed using non-opioid biopolymer technology. | ||
| optimotionimplants.com | 2016 | Orlando, United States | $2.25M | Knee replacement implants and surgical devices are developed. |
Detailed competitors of Sparta Biomedical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sparta Biomedical
The website of Sparta Biomedical (spartabiomedical.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▲ 56.1% vs previous month
Top companies in Orthopedics
3 companies that operate in the same segment as Sparta Biomedical (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sparta Biomedical
Complete news archive for Sparta Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sparta Biomedical
Sparta Biomedical was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Sparta Biomedical is headquartered in United States. It is registered at North Carolina, United States.
Sparta Biomedical is a funded company, having raised a total of $5M across 2 funding rounds to date. The company's 1st funding round was a Seed of $5M, raised on Dec 2021.
Sparta Biomedical was founded in 2017 and is based in Research Triangle Park, United States. Advancements in biomedical engineering are focused on by the company, particularly through the creation of a synthetic cartilage platform. This platform is designed to assist orthopedic surgeons in restoring patient movement. Operations center on research and development within the orthopedics sector, with services aimed at improving surgical outcomes.
Sparta Biomedical's top competitors include Moximed, Allay Therapeutics and Optimotion Implants.
Sparta Biomedical offers Galene Platform and Ormi™ Implant.
Sparta Biomedical has 2 investors. Key investors include Duke University, and Nanosha.
Sparta Biomedical operates through Sparta Biomedical Inc.